123 related articles for article (PubMed ID: 36435971)
1. Diagnostic performance of perfusion-weighted imaging combined with serum MMP-2 and -9 levels in tumor recurrence after postoperative concomitant chemoradiotherapy of glioblastoma.
Liu W; Li Z
J Clin Ultrasound; 2023 Mar; 51(3):563-570. PubMed ID: 36435971
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
[TBL] [Abstract][Full Text] [Related]
3. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
[TBL] [Abstract][Full Text] [Related]
5. Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients.
Kim TH; Yun TJ; Park CK; Kim TM; Kim JH; Sohn CH; Won JK; Park SH; Kim IH; Choi SH
Oncotarget; 2017 Mar; 8(12):20340-20353. PubMed ID: 27823971
[TBL] [Abstract][Full Text] [Related]
6. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Feng A; Yuan P; Huang T; Li L; Lyu J
Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
[TBL] [Abstract][Full Text] [Related]
8. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
[TBL] [Abstract][Full Text] [Related]
9. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pseudoprogression in post-treatment glioblastoma using dynamic susceptibility contrast-derived oxygenation and microvascular transit time heterogeneity measures.
Park JE; Kim HS; Kim N; Borra R; Mouridsen K; Hansen MB; Kim YH; Hong CK; Kim JH
Eur Radiol; 2024 May; 34(5):3061-3073. PubMed ID: 37848773
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging.
Wang YL; Chen S; Xiao HF; Li Y; Wang Y; Liu G; Lou X; Ma L
Radiother Oncol; 2018 Oct; 129(1):68-74. PubMed ID: 29398151
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging.
Lee EK; Choi SH; Yun TJ; Kang KM; Kim TM; Lee SH; Park CK; Park SH; Kim IH
Korean J Radiol; 2015; 16(6):1341-8. PubMed ID: 26576125
[TBL] [Abstract][Full Text] [Related]
13. Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaging.
Kim JH; Choi SH; Ryoo I; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Sohn CH; Park SH; Kim IH
PLoS One; 2014; 9(11):e113587. PubMed ID: 25419975
[TBL] [Abstract][Full Text] [Related]
14. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
15. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
[TBL] [Abstract][Full Text] [Related]
16. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
Bao S; Watanabe Y; Takahashi H; Tanaka H; Arisawa A; Matsuo C; Wu R; Fujimoto Y; Tomiyama N
Magn Reson Med Sci; 2019 Jan; 18(1):53-61. PubMed ID: 29848919
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
[TBL] [Abstract][Full Text] [Related]
18. Objective and quantitative evaluation of angiographic vascularity in meningioma: parameters of dynamic susceptibility contrast-perfusion-weighted imaging as clinical indicators of preoperative embolization.
Adachi K; Murayama K; Hayakawa M; Hasegawa M; Muto J; Nishiyama Y; Ohba S; Hirose Y
Neurosurg Rev; 2021 Oct; 44(5):2629-2638. PubMed ID: 33215366
[TBL] [Abstract][Full Text] [Related]
19. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
20. Utility of arterial spin labeling perfusion magnetic resonance imaging in prediction of angiographic vascularity of meningiomas.
Yoo RE; Yun TJ; Cho YD; Rhim JH; Kang KM; Choi SH; Kim JH; Kim JE; Kang HS; Sohn CH; Park SW; Han MH
J Neurosurg; 2016 Sep; 125(3):536-43. PubMed ID: 26824378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]